ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-06
DOI
10.1038/s41388-020-1194-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Furin inhibition prevents hypoxic and TGFβ-mediated blood-brain barrier disruption
- (2019) Julia Baumann et al. EXPERIMENTAL CELL RESEARCH
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
- (2018) Jei Ha Lee et al. Scientific Reports
- Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
- (2018) Changliang Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The proprotein convertase furin in tumour progression
- (2017) Patricia Jaaks et al. INTERNATIONAL JOURNAL OF CANCER
- Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study
- (2017) Kezia Gaitskell et al. INTERNATIONAL JOURNAL OF CANCER
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Epithelial–mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways
- (2016) D Fang et al. ONCOGENE
- The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
- (2016) Jessica L. Geiger et al. ORAL ONCOLOGY
- Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
- (2016) Pradeep Chaluvally-Raghavan et al. Cell Reports
- Erythropoietin Stimulates Tumor Growth via EphB4
- (2015) Sunila Pradeep et al. CANCER CELL
- A Small-Molecule Furin Inhibitor Inhibits Cancer Cell Motility and Invasiveness
- (2015) Julia M. Coppola et al. NEOPLASIA
- Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers
- (2014) Pradeep Chaluvally-Raghavan et al. CANCER CELL
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse ESC Fates
- (2013) Guanyi Huang et al. STEM CELLS
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells
- (2012) Yong-Chao Ma et al. PLoS One
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now